Tonix Pharmaceuticals HLDG C
13F holders, Q2 2024 (June 30)22holders
$0.69avg. 13F price*
At the end of Q2 2024, 22 institutions reported holding Tonix Pharmaceuticals HLDG C in their 13F filings. The largest holders were Prudential Financial Inc. ($68K), Alyeska Investment Group, L.P. ($44K) and Acadian Asset Management LLC ($39K).
- Company
- Tonix Pharmaceuticals HLDG C
- CUSIP
- 890260847
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $207K |
| Exits | 0 | $0 |
Ownership 22 holders
| Prudential Financial Inc. | 0.00% | New | 97,707 | $68K |
| Alyeska Investment Group, L.P. | 0.00% | New | 62,500 | $44K |
| Acadian Asset Management LLC | 0.00% | New | 57,762 | $39K |
| Vanguard Group Inc. | 0.00% | New | 25,395 | $18K |
| HRT Financial LP | 0.00% | New | 21,514 | $15K |
| Geode Capital Management, LLC | 0.00% | New | 16,546 | $12K |
| Jane Street Group, LLC | 0.00% | New | 10,950 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 5,042 | $4K |
| BlackRock Inc. | 0.00% | New | 1,269 | $885 |
| Qube Research & Technologies Ltd | 0.00% | New | 302 | $210 |
| Morgan Stanley | 0.00% | New | 251 | $176 |
| UBS Group AG | 0.00% | New | 50 | $35 |
| Bank of America Corp. | 0.00% | New | 28 | $19 |
| BNP Paribas Financial Markets | 0.00% | New | 10 | $7 |
| JPMorgan Chase & Co. | 0.00% | New | 9 | $6 |
| Nvwm, LLC | 0.00% | New | 5 | $3 |
| CENTRAL TRUST Co | 0.00% | New | 1 | $1 |
| Allworth Financial LP | 0.00% | New | 1 | $1 |
| Global Retirement Partners, LLC | 0.00% | New | 2 | $1 |
| Activest Wealth Management | 0.00% | New | 1 | $1 |
| Planning Capital Management Corp | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | New | 4 | $0 |
"% of holder's portfolio" is TONIX PHARMACEUTICALS HLDG C's weight in each manager's 13F, not the share of Tonix Pharmaceuticals HLDG C the manager owns.